1. Home
  2. BEAM vs FRME Comparison

BEAM vs FRME Comparison

Compare BEAM & FRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • FRME
  • Stock Information
  • Founded
  • BEAM 2017
  • FRME 1893
  • Country
  • BEAM United States
  • FRME United States
  • Employees
  • BEAM N/A
  • FRME N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • FRME Major Banks
  • Sector
  • BEAM Health Care
  • FRME Finance
  • Exchange
  • BEAM Nasdaq
  • FRME Nasdaq
  • Market Cap
  • BEAM 1.9B
  • FRME 2.1B
  • IPO Year
  • BEAM 2020
  • FRME N/A
  • Fundamental
  • Price
  • BEAM $23.93
  • FRME $37.49
  • Analyst Decision
  • BEAM Buy
  • FRME Buy
  • Analyst Count
  • BEAM 10
  • FRME 5
  • Target Price
  • BEAM $47.00
  • FRME $43.90
  • AVG Volume (30 Days)
  • BEAM 1.0M
  • FRME 290.4K
  • Earning Date
  • BEAM 11-05-2024
  • FRME 10-24-2024
  • Dividend Yield
  • BEAM N/A
  • FRME 3.77%
  • EPS Growth
  • BEAM N/A
  • FRME N/A
  • EPS
  • BEAM N/A
  • FRME 3.01
  • Revenue
  • BEAM $349,643,000.00
  • FRME $593,089,000.00
  • Revenue This Year
  • BEAM N/A
  • FRME N/A
  • Revenue Next Year
  • BEAM $9.04
  • FRME $2.14
  • P/E Ratio
  • BEAM N/A
  • FRME $12.38
  • Revenue Growth
  • BEAM 328.73
  • FRME N/A
  • 52 Week Low
  • BEAM $18.85
  • FRME $28.08
  • 52 Week High
  • BEAM $49.50
  • FRME $42.45
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 52.24
  • FRME 52.37
  • Support Level
  • BEAM $21.79
  • FRME $36.18
  • Resistance Level
  • BEAM $24.95
  • FRME $38.22
  • Average True Range (ATR)
  • BEAM 1.31
  • FRME 1.04
  • MACD
  • BEAM 0.15
  • FRME -0.04
  • Stochastic Oscillator
  • BEAM 52.79
  • FRME 50.11

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About FRME First Merchants Corporation

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.

Share on Social Networks: